Facebook
Twitter
LinkedIn
Forward
Keeping Up with IRA
Pricing: Free for Members and $30 for Non-Members
The information presented in this activity is current as of August 29, 2023.
Course Description
Going into the second half of 2023, the Inflation Reduction Act (IRA) continues to foreshadow potential changes for every health care stakeholder, from Medicare beneficiaries to commercial plans, manufacturers, and everything in between. It may be tempting to think that the IRA will have a limited impact outside of Medicare, but that is not the case. How will IRA affect commercial plans and manufacturers? What are the newest regulatory updates from the Department of Health and Human Services?
This session will provide up-to-date insight into how IRA will leave its mark outside of Medicare, explore initial signs of pricing strategies from manufacturers, and help attendees stay up-to-date on recent actions toward drug price negotiation.
Target Audience
Pharmacists who practice in managed care settings.
Learning Objectives
At the completion of this activity, participants should be able to
Summarize the key drug pricing provisions and timeline of implementation of the Inflation Reduction Act (IRA).
Describe how CMS plans to approach drug pricing negotiations.
Discuss recent lawsuits challenging government negotiation of prescription drug prices and their impact on drug price negotiations for 2026.
Explain how government negotiation of prescription drug prices will impact the generic and biosimilar markets and commercial health plans.
Faculty
Melissa Andel, MPP
Principal
CommonHealth Solutions LLC
Moderator
Drake Reiter, PharmD
Advisor, Pharmacy Product & Trend
Priority Health
Financial Relationship Disclosures
| Faculty/Reviewer/Planner | Reported Relevant Financial Relationships |
| Melissa Andel Faculty | Disclosed no relevant financial relationships. |
| John Joffer, PharmD Reviewer | Disclosed no relevant financial relationships. |
Brittany V. Henry, PharmD, MBA | Disclosed no relevant financial relationships. |
| Ryan Shan Planner | Disclosed no relevant financial relationships. |
- If applicable, relevant financial relationships have been mitigated and documented.
- Content has undergone a peer review to ensure content validity.
Accreditation:
The Academy of Managed Care Pharmacy (AMCP) is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
ACPE UAN:0233-0000-23-041-H03-P • Activity Type: Knowledge-Based
Contact Hours: 1
Release Date: August 29, 2023 • Expiration Date: December 31, 2024
Activity Fee: Free for Members and $30 for Non-Members
Participants should claim continuing pharmacy education (CPE) credit for this home study activity only if they have not claimed credit for the live activity presented at eLearning Day 2023. CPE credit will be processed through the AMCP Learn portal and reported directly to CPE Monitor. Please allow 72 hours for processing and posting in your NABP account.
To receive credit for an online activity you must:
- Review the full content of the activity.
- Successfully complete the post-test (required to pass with a score of 70% or higher, it may be taken a maximum of three times).
- Complete a specific activity evaluation.
Available Credit
- 1.00 ACPE
The Academy of Managed Care Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. - 1.00 Certificate of Completion
Price
Required Hardware/software
System Requirements Courses and learning activities are delivered via your Web browser and Acrobat PDF. For all activities, you should have a basic comfort level using a computer and navigating websites. View the minimum technical and system requirements for continuing education online learning activities